MedPath

武汉正同药业有限公司

Ownership
-
Established
2011-05-17
Employees
-
Market Cap
-
Website
www.whztyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

5

NMPA:5

Drug Approvals

Diclofenac Sodium Suppositories(Ⅱ)

Product Name
同杜叮
Approval Number
国药准字H20051720
Approval Date
Jun 16, 2020
NMPA

Sulfasalazine Suppositories

Product Name
柳氮磺吡啶栓
Approval Number
国药准字H19994081
Approval Date
Jun 16, 2020
NMPA

Nitrofurantoin Suppositories

Product Name
呋喃妥因栓
Approval Number
国药准字H42022511
Approval Date
Jun 16, 2020
NMPA

Diclofenac Sodium Suppositories

Product Name
双氯芬酸钠栓
Approval Number
国药准字H42021748
Approval Date
Jun 16, 2020
NMPA

Diclofenac Sodium Suppositories

Product Name
双氯芬酸钠栓
Approval Number
国药准字H42021749
Approval Date
Jun 16, 2020
NMPA

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath